share_log
Reuters ·  May 9 07:05
Akebia Therapeutics: Existing Cash Resources Sufficient to Fund Current Operating Plan, Including U.S. Vafseo Launch, for at Least Next 2 Years
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment